Industry & academia combine to support synthesis of squaric acid monoamides as building blocks for drug discovery

Global sustainable laboratory equipment visionaries, Asynt, have collaborated with Kingston University (London, UK) and renowned worldwide chemical products supplier, Key Organics, to develop an accessible new synthetic compound library.

Adherence Matters for CVD Secondary Prevention in CPAP Users

Good treatment adherence made a case for the controversial idea of continuous positive airway pressure (CPAP) as secondary cardiovascular disease prevention for people with obstructive

October 6, 2023

Clearmind Medicine Closes US$2.25 Million Public Offering – Psychedelic Alpha

Tel Aviv, Israel / Vancouver, Canada, Sept. 18, 2023 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (NASDAQ: CMND) (CSE: CMND), (FSE: CWY) (“Clearmind”), a biotech company

September 18, 2023

Maryland biotech gets green light for stem cell-derived therapy for diabetes, aiming to compete with Vertex

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.